The U.S. equities market snapped a recent losing streak on June 29, 2026, with the S&P 500 climbing 1.2% and the Nasdaq Composite advancing 2.1%. This broad recovery was supported by cooling geopolitical tensions between the U.S. and Iran alongside a drop in the 10-year Treasury yield toward 4.40%. Against this risk-on backdrop, rotational currents drove sharp re-ratings across semiconductor capital equipment, biotechnology, and housing, while massive M&A announcements dominated individual stock narratives.
AI Hardware & Semi-Cap Resurgence
Semiconductor equipment and AI infrastructure names dominated the session’s upside, heavily fueled by analyst upgrades and expanding capital expenditure forecasts. AMAT (+10.82%) and LRCX (+8.39%) hit fresh highs after KeyBanc and Cantor Fitzgerald issued major price target upgrades, citing long-term Wafer Fabrication Equipment (WFE) forecasts expanding to $140 billion by 2030 and newly launched AI DRAM solutions. KLAC (+11.97%) joined the rally on Samsung 1.4nm advancements and an aggressive short squeeze.
Storage and thermal management plays were swept up in the same structural AI tailwinds. Hard disk drive manufacturers WDC (+11.16%) and STX (+7.63%) popped on Melius Research upgrades highlighting a multi-year supply shortage for high-density enterprise storage. FLEX (+8.77%) advanced on momentum from a liquid-cooling partnership with Dell and S&P 500 inclusion, while GLW (+15.67%) saw massive mechanical buying as the annual FTSE Russell Reconstitution shifted it from value to growth indices on the back of its AI optical infrastructure partnerships.
M&A Boom and Bust
Dealmaking drove some of the week's most extreme moves, yielding mixed reactions from institutional capital. TECH (+27.50%) transitioned immediately into a merger arbitrage play after Merck KGaA announced a $73-per-share all-cash buyout. In the UK, SGRO.L (+18.01%) surged after Prologis launched an unsolicited takeover bid that highlighted the embedded value of its pan-European logistics and data center portfolio—a bid the U.S. giant later sweetened to £14 billion.
Conversely, ON (-32.67%) suffered a brutal selloff. The market balked at its $7 billion all-stock acquisition of Synaptics, punishing the company over severe shareholder dilution and a lengthy integration timeline expected to stretch into mid-2027.
Macro Relief and Biotechnology Turnarounds
Broader macroeconomic shifts acted as powerful sector catalysts. BLDR (+17.04%) rocketed off multi-year lows following the passage of the bipartisan 21st Century ROAD to Housing Act, which—combined with retreating bond yields—ignited massive short-covering across residential building materials. PANW (+9.14%) hit all-time highs as easing U.S.-Iran tensions and a bullish $240 billion global cybersecurity forecast from UBS lured institutions back into platform software. On the downside, ALB (-17.21%) plummeted after China's CATL secured regulatory approval to restart its massive Jianxiawo lithium mine, crushing benchmark lithium futures on supply expansion fears.
Meanwhile, a thawing biotech funding environment sparked structural re-ratings in healthcare. CRL (+24.24%) surged after Morgan Stanley noted that improving biopharma funding is finally translating into increased R&D bookings. MRNA (+17.45%) successfully shifted its narrative away from a declining COVID-19 vaccine manufacturer, riding a unanimous FDA panel endorsement for its seasonal flu vaccine and a pipeline presentation detailing its broader oncology and rare disease strategy.
Corporate Catalysts and Governance Risks
Stock-specific developments drove stark divergences outside of major sector themes. TSLA (+8.46%) enjoyed its best session in over a year after rolling out FSD v14 Lite to older Hardware 3 vehicles, erasing hardware obsolescence fears ahead of highly anticipated Q2 delivery reports. CHTR (+9.38%) advanced on reports of executive-level talks to route SpaceX’s direct-to-cell traffic across its terrestrial network, offering a new wholesale revenue stream. AXON (+9.85%) gained on robust fundamentals and software demand, though initial momentum was sparked by disclosures that Donald Trump purchased shares shortly before a $220 million ICE procurement notice.
Leadership and compliance issues weighed heavily elsewhere. CPRT (-8.02%) dropped to a 52-week low after CEO Jeff Liaw abruptly resigned, handing the reins back to former CEO Jay Adair amid softening U.S. salvage volumes. Most severely, SMCI (-20.61%) plummeted following police raids on its Taiwan offices investigating the alleged smuggling of restricted Nvidia AI chips to China, compounding recent exhaustion from a dilutive $7 billion capital raise.
What to Watch
- TSLA Q2 vehicle deliveries: Market expectations are elevated following the FSD v14 Lite rollout, putting pressure on actual production numbers and automotive margins.
- SGRO.L Arbitrage Window: Shares will likely remain anchored near the 1,031.7p offer price as the August 12 Takeover Panel deadline approaches, bringing binary deal-completion risks.
- AMAT Valuation Risk: Trading at ~54x trailing P/E after its 173% YTD rally, the equipment maker is priced for perfection heading into Q3 earnings.
- SMCI Legal Fallout: Institutional trust remains impaired until the Taiwan export compliance investigation yields definitive findings.